logo
Plus   Neg
Share
Email

Regeneron Pharmaceuticals Board Approves $1 Bln Share Buyback - Quick Facts

While reporting its third-quarter financial results on Tuesday, Regeneron Pharmaceuticals Inc. (REGN) said its board of directors authorized a share repurchase program to repurchase up to $1.0 billion of the company's common stock.

The program has no time limit and can be discontinued at any time, the company added.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Polaris Industries Inc. is recalling certain Ranger and General Utility, as well as All-Terrain vehicles citing risks of crash, the U.S. Consumer Product Safety Commission said in a statement. The Medina, Minnesota-based company has called back about 26,730 units of Model Year 2019 - 2020 Ranger XP 1000 & Model Year 2020 General XP 1000 Utility vehicles. Gilead Sciences Inc. (GILD) said Friday that the European Commission has granted conditional marketing authorization for Veklury or remdesivir as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19. FedEx is asking NFL team Washington Redskins to change its name for its racist connotations. The delivery services company, which is a major sponsor for the team, made the suggestion following increasing pressure from its investors amid the ongoing protests against racial injustice and inequality that arose from the killing of African-American George Floyd.
Follow RTT